Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
Public ClinicalTrials.gov record NCT01451645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01451645
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Interventions
- Colchicine (Colcrys®) Drug
- placebo Drug
- allopurinol Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2011
- Primary completion
- Jul 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- May 11, 2014
2011 – 2012
United States locations
- U.S. sites
- 37
- U.S. states
- 25
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alabaster | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Trumbull | Connecticut | — | — |
| Not listed | DeBary | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Canton | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Reisterstown | Maryland | — | — |
| Not listed | Bingham Farms | Michigan | — | — |
| Not listed | Brooklyn Center | Minnesota | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Billings | Montana | — | — |
| Not listed | Elizabeth | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Hickory | North Carolina | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Reading | Pennsylvania | — | — |
| Not listed | West Reading | Pennsylvania | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Johnson City | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Seattle | Washington | — | — |
| Not listed | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01451645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01451645 live on ClinicalTrials.gov.